Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) Director David P. Bolger sold 7,055 shares of the stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $70.88, for a total transaction of $500,058.40. Following the completion of the sale, the director now owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. The trade was a 8.28 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Ryan Specialty Price Performance
Shares of RYAN stock traded up $0.37 during midday trading on Wednesday, reaching $75.44. 19,527 shares of the company were exchanged, compared to its average volume of 867,771. Ryan Specialty Holdings, Inc. has a 12 month low of $41.49 and a 12 month high of $75.50. The company has a market cap of $19.75 billion, a P/E ratio of 97.53, a PEG ratio of 1.69 and a beta of 0.62. The company’s 50 day moving average price is $69.27 and its two-hundred day moving average price is $62.80. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting analysts’ consensus estimates of $0.41. The business had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The business’s revenue for the quarter was up 20.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.32 EPS. On average, sell-side analysts expect that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current year.
Ryan Specialty Announces Dividend
Institutional Trading of Ryan Specialty
Large investors have recently added to or reduced their stakes in the business. Securian Asset Management Inc. acquired a new position in shares of Ryan Specialty in the 2nd quarter valued at $474,000. Xponance Inc. raised its position in shares of Ryan Specialty by 67.2% in the 2nd quarter. Xponance Inc. now owns 20,686 shares of the company’s stock valued at $1,198,000 after acquiring an additional 8,312 shares during the period. Geneva Partners LLC acquired a new stake in Ryan Specialty during the 3rd quarter worth approximately $2,537,000. Susquehanna Fundamental Investments LLC raised its holdings in Ryan Specialty by 2,354.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 100,614 shares of the company’s stock worth $5,827,000 after buying an additional 96,514 shares during the period. Finally, Jennison Associates LLC grew its stake in shares of Ryan Specialty by 60.2% during the 3rd quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock worth $68,054,000 after acquiring an additional 385,366 shares in the last quarter. 84.82% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several brokerages have commented on RYAN. Bank of America raised their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. Barclays upped their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a report on Thursday, November 21st. Wells Fargo & Company increased their price target on shares of Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a report on Thursday, October 10th. JPMorgan Chase & Co. increased their target price on shares of Ryan Specialty from $54.00 to $56.00 and gave the company an “underweight” rating in a report on Friday, August 2nd. Finally, UBS Group increased their target price on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a report on Tuesday, August 13th. One analyst has rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $71.67.
Read Our Latest Research Report on RYAN
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading
- Five stocks we like better than Ryan Specialty
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is the Australian Securities Exchange (ASX)
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What Is WallStreetBets and What Stocks Are They Targeting?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.